Dr. Gabriel Melki, MD

NPI: 1194247213
Total Payments
$657.44
2024 Payments
$657.44
Companies
7
Transactions
11

Payment Breakdown by Category

Food & Beverage$657.44 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $657.44 11 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $208.17 5 $0 (2024)
Phathom Pharmaceuticals, Inc. $125.00 1 $0 (2024)
Intercept Pharmaceuticals, Inc. $122.70 1 $0 (2024)
Gilead Sciences, Inc. $118.56 1 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $31.08 1 $0 (2024)
Lilly USA, LLC $28.03 1 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.90 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $657.44 11 ABBVIE INC. ($208.17)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/12/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $23.82 General
Category: GASTROENTEROLOGY
10/02/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $24.52 General
Category: GASTROENTEROLOGY
09/24/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $26.17 General
Category: GASTROENTEROLOGY
09/20/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $25.78 General
Category: ENDOCRINOLOGY
09/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $23.90 General
Category: Gastroenterology
09/17/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $31.08 General
Category: INTERNAL MEDICINE
09/11/2024 Lilly USA, LLC Food and Beverage In-kind items and services $28.03 General
09/10/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $122.70 General
Category: Hepatology / Gastroenterology
05/29/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: GASTROENTEROLOGY
03/21/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $107.88 General
Category: IMMUNOLOGY
03/12/2024 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $118.56 General
Category: HCV

About Dr. Gabriel Melki, MD

Dr. Gabriel Melki, MD is a Gastroenterology healthcare provider based in Waterville, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1194247213.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gabriel Melki, MD has received a total of $657.44 in payments from pharmaceutical and medical device companies, with $657.44 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($657.44).

Practice Information

  • Specialty Gastroenterology
  • Location Waterville, ME
  • Active Since 07/11/2017
  • Last Updated 07/31/2024
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1194247213

Products in Payments

  • VOQUEZNA (Drug) $125.00
  • OCALIVA (Drug) $122.70
  • Epclusa (Drug) $118.56
  • RINVOQ (Biological) $107.88
  • LINZESS (Drug) $74.51
  • ENTYVIO (Biological) $31.08
  • CREON (Drug) $25.78
  • XIFAXAN (Drug) $23.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Waterville